Skip to main content

Table 3 Incidence of worst grade for most common drug-related non haematological adverse events per cycle

From: Phase I study of OM-174, a lipid A analogue, with assessment of immunological response, in patients with refractory solid tumors

 

NCI CTC grading

Adverse Events

All grades N (%)

G3 N (%)

G4 N (%)

Chills

12 (70)

-

-

Fever

7 (41)

-

-

Nausea

4 (23)

-

-

Vomiting

4 (23)

-

-

Fatigue

4 (23)

-

-

Headache

3 (17)

-

-

Diarrhoea

3 (17)

-

-

High blood pressure

1 (7)

-

-

Dizziness

1 (7)

-

-

Somnolence

1 (7)

-

-

Dysphagia

1 (7)

-

-

Cholestasis

1 (7)

-

-

Cytolysis

1 (7)

-

-

bronchospasm

1 (7)

-

-